52 related articles for article (PubMed ID: 22102)
1. [Psychotropic drugs and adenylate cyclase (author's transl)].
Honda F
Tanpakushitsu Kakusan Koso; 1977; 22(6):822-6. PubMed ID: 22102
[No Abstract] [Full Text] [Related]
2. How do antipsychotic drugs work?
Iversen LL
Neurosci Res Program Bull; 1975 Aug; 13 Suppl():29-51. PubMed ID: 241033
[No Abstract] [Full Text] [Related]
3. Mechanism for selectively inhibiting the activation of cyclic nucleotide phosphodiesterase and adenylate cyclase by antipsychotic agents.
Weiss B; Levin RM
Adv Cyclic Nucleotide Res; 1978; 9():285-303. PubMed ID: 27079
[No Abstract] [Full Text] [Related]
4. [Blockade of the dopamine receptor: a possible mechanism of action of antipsychotic drugs (author's transl)].
Karobath ME
Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):151-61. PubMed ID: 1233518
[TBL] [Abstract][Full Text] [Related]
5. Postsynaptic serotonin-sensitive adenylate cyclase in the central nervous system. II. Comparison with dopamine- and isoproterenol-sensitive adenylate cyclases in rat brain.
Enjalbert A; Hamon M; Bourgoin S; Bockaert J
Mol Pharmacol; 1978 Jan; 14(1):11-23. PubMed ID: 24167
[No Abstract] [Full Text] [Related]
6. [Effect of psychotropic drugs on the central dopamine metabolism (example: neuroleptics)].
Havemann U
Arzneimittelforschung; 1981; Suppl 27():18-22. PubMed ID: 6118158
[No Abstract] [Full Text] [Related]
7. [Proceedings: Dopamine receptor and antipsychotic effects (author's transl)].
Karobath M
Arzneimittelforschung; 1976; 26(6):1029-30. PubMed ID: 9103
[No Abstract] [Full Text] [Related]
8. Effect of narcotic dependence and withdrawal on striatal dopamine-sensitive adenylate cyclase and synaptosomal cyclic AMP metabolism.
Merali Z; Tsang B; Singhal RL; Hrdina PD
Res Commun Chem Pathol Pharmacol; 1976 May; 14(1):29-37. PubMed ID: 180579
[TBL] [Abstract][Full Text] [Related]
9. [Action of etmozin and ethacizin on dopaminergic adenylate cyclase of the striate system of the brain].
Baldenkov GN; Ratner EI; Rozenshtraukh LV; Tkachuk VA
Biull Eksp Biol Med; 1984 Oct; 98(10):448-50. PubMed ID: 6149776
[TBL] [Abstract][Full Text] [Related]
10. Modulators of cyclic AMP systems.
Hess SM; Chasin M; Free CA; Harris DN
Adv Biochem Psychopharmacol; 1975; (14):153-67. PubMed ID: 242200
[TBL] [Abstract][Full Text] [Related]
11. Does morphine inhibit prostaglandin-stimulated adenylate cyclase in the rat brain?
Schmidt WK; Way EL
Proc West Pharmacol Soc; 1976; 19():55-9. PubMed ID: 186814
[No Abstract] [Full Text] [Related]
12. Histamine-stimulated adenylate cyclase: blockade by imipramine and its analogues.
Palmer GC; Wagner HR; Palmer SJ; Manian AA
Commun Psychopharmacol; 1977; 1(1):61-9. PubMed ID: 203428
[No Abstract] [Full Text] [Related]
13. Psychopharmacological agents and the cyclic AMP system of rat brain.
Uzunov P; Weiss B
Adv Cyclic Nucleotide Res; 1972; 1():435-53. PubMed ID: 4146714
[No Abstract] [Full Text] [Related]
14. [Problem of neuronal reception and the dopamine hypothesis of schizophrenia].
Lideman RR; Zlobina GP; Mukhin AG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):762-9. PubMed ID: 6106337
[No Abstract] [Full Text] [Related]
15. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
Marshall AM; Mishra RK
Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
[No Abstract] [Full Text] [Related]
16. [Effects of hexoprenaline on cyclic AMP content and on activities of adenyl cyclase of lung, liver and heart in rats (author's transl)].
Ikegami K; Hirano S; Imamura H
Yakugaku Zasshi; 1976 Sep; 96(9):1122-6. PubMed ID: 185352
[No Abstract] [Full Text] [Related]
17. Is adenylate cyclase the dopamine receptor?
Arbuthnott GW; Attree TJ; Eccleston D; Loose RW; Martin MJ
Med Biol; 1974 Oct; 52(5):350-3. PubMed ID: 4372496
[No Abstract] [Full Text] [Related]
18. [Cyclic nuclestides and phosphorylated proteins in neuronal function (author's transl)].
Uno I
Tanpakushitsu Kakusan Koso; 1978; 23(4):264-76. PubMed ID: 26106
[No Abstract] [Full Text] [Related]
19. Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D(2)-like receptors.
Montezinho LP; Mørk A; Duarte CB; Penschuck S; Geraldes CF; Castro MM
Bipolar Disord; 2007 May; 9(3):290-7. PubMed ID: 17430304
[TBL] [Abstract][Full Text] [Related]
20. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
